DRKS00020248
Completed
Not Applicable
A retrospective non-interventional study evaluating retention rate of Everolimus as add-on epilepsy therapy in adult patients with tuberose sclerosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Q85.1
- Sponsor
- Epilepsiezentrum Kork
- Enrollment
- 45
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis epilepsy
- •at least 1 epileptic seizure in the year before the onset of everolimus
- •Clinically and / or genetically confirmed tuberous sclerosis
- •Treatment with everolimus between 01\.01\.1999 and 30\.04\.2019
- •start treatment with everolimus in adulthood (18 years or older)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40
Active, not recruiting
Not Applicable
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disordersACTRN12610000558022Ipsen Pty Ltd70
Completed
Not Applicable
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia BD67Hereditary factor IX deficiencyDRKS00015079CSL Behring GmbH73
Completed
Not Applicable
on-interventional retrospective study to evaluate the menstrual cycle profiles and quality of life of women after the use of the new vaginal ring GinoRing® delivering 0.120mg etonogestrel and 0.015mg ethinylestradiol per dayN92.0Excessive and frequent menstruation with regular cycleDRKS00014982Exeltis Germany GmbH103
Completed
Not Applicable
A non-interventional, cross-sectional study to investigate the burden of disease in patients with uncontrolled severe asthma in Japan by internet surveyBronchial asthmaJPRN-UMIN000028081AstraZeneca K.K.4,000